Moreover, we found that enhancer clusters dramatically enhance TRAIL upregulation by IFNα in breast and lung cancer cells but that the consequent increase in TRAIL expression at the protein level does not result in an increase in extracellular TRAIL, neither in the cancer cell supernatants nor on their surface. The gene discussed is IFNA2; the disease is cancer.